Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner
SUBSCRIBE FOR FREE
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner
Cancerworld Magazine > Articles > Equity:The Word That Shaped Her Career From The Lab To The White House:The Story Of Catharine Young
  • Articles
  • Profiles

Equity:The Word That Shaped Her Career From The Lab To The White House:The Story Of Catharine Young

  • 4 July 2025
  • Shushan Hovsepyan
Equity:The Word That Shaped Her Career From The Lab To The White House:The Story Of Catharine Young
Total
0
Shares
0
0
0
0
0

When Catharine Young talks about inequity, she isn’t referring to it in abstract terms. She grew up in South Africa at the end of apartheid, when systemic injustice was not just visible, it was part of daily life. That early exposure to imbalance and transformation would go on to define her career: one rooted in science, but driven by policy. One committed to making breakthroughs reach those who need them most.

“It all began with me growing up in South Africa, where I was born and raised, during a time of incredible transformation,” she recalls. “I witnessed a system that was completely inequitable…”

That understanding—that big problems require united, systemic solutions—has guided Catharine through every stage of her career. From earning a PhD in biomedical sciences with a focus on neuroscience, to transitioning into policy leadership roles, she has consistently moved toward greater
impact.

“I quickly realized that scientific breakthroughs, while amazing, are not enough. They have to reach people who need them the most.”

Her shift from academia into policy was more than a career pivot—it was a values-driven decision. For the past decade, she’s been applying her scientific training to some of the world’s biggest health challenges, culminating in her most high-profile role yet: Assistant Director for Policy and International Engagement for the Biden Cancer Moonshot.

Inside the Cancer Moonshot

“It was one of the greatest privileges of my life to be able to serve in that role,” she says.

She worked at the White House Office of Science and Technology Policy, helping to implement the ambitious vision set by President Biden and First Lady Dr. Jill Biden. The initiative’s core objectives were twofold: reduce the U.S. cancer death rate by 50% in 25 years and improve the experience of people living with and surviving cancer.

“My role evolved over my time at the White House to think about how we take the mission and the vision of the cancer moonshot globally.”

For Catharine, global equity was non-negotiable. While the U.S. faces its cancer burden, most cancer deaths occur in low- and middle-income countries, where access to diagnostics, treatments, and technologies remains far out of reach for many.

“We saw so many amazing things happen during that time and… the beauty of what happens when you have, even at the country levels, countries coming together to decide that something was not acceptable anymore.”

Her work led to collaborations that transcended borders, unifying governments, public health institutions, and advocates in a shared goal of reducing disparities in cancer care.

The Human Element

Though Catharine has worked with some of the most powerful leaders in the world, she remains deeply grounded in the stories of patients and scientists.

“I will say, though, that many of the greatest teachers that I’ve had and motivators are those— the patients who have turned their immense pain into advocacy.”

She adds: “I am inspired every day by the scientists who turn their incredible curiosity about the world and their motivation to really see impactful change happen around the world… and to work tirelessly for breakthroughs for people that they will never meet.”

It’s that combination of empathy and systems-level thinking that makes her a unique voice in cancer policy. She believes the greatest change comes not from lone individuals but from sustained collaboration.

“Everybody that I have had the privilege of crossing paths with in my career has underscored that change as a whole is certainly a collective effort.”

On Resilience

When asked about resilience—a theme she’s written about publicly—she doesn’t hesitate.

“I think my whole career has been a test of resilience.” Working in cancer, she notes, means grappling not just with biology, but with complex systems, fragmented infrastructures, and emotionally heavy realities. “There are so many aspects that need to be improved for cancer patients that resilience is a trait that is required to push change forward.”

A Legacy of Shared Purpose

As her time at the White House came to a close, Young was reflective, not about her achievements, but about the larger movement she had been part of.

“Truly, the legacy that we’re leaving behind belongs to President Biden and First Lady, who were the true leaders in this space… They were the ones who galvanized an entire community, an entire country, an entire world behind this one singular
mission.”

For Catharine, the legacy isn’t a single project or policy—it’s the ongoing, global fight to ensure no one is left behind in cancer care.

“It is the work that was done, and it will be the work that continues to improve the lives of patients around the world.”

Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Related Topics
  • Access to Healthcare
  • Biden Administration
  • Biomedical Research
  • cancer moonshot
  • cancer policy
  • cancer research
  • Cathrine Young
  • Global Collaboration
  • Global Health Equity
  • health disparities
  • Health Systems Innovation
  • patient advocacy
  • Public Health Leadership
  • Resilience in Healthcare
  • Science and Policy
  • South Africa
  • translational science
  • White House
  • White House Office of Science and Technology Policy
  • Women in Leadership
  • Women in STEM
Shushan Hovsepyan

Previous Article
  • Articles
  • Profiles

Curious, Rejected,Accepted: An ESO Fellow’s Road to Becoming an Oncologist

  • 3 July 2025
  • Amalya Sargsyan
View Post
Next Article
  • Articles
  • Profiles

Suheir Rasul: Protecting Human Dignity

  • 4 July 2025
  • Gevorg Tamamyan
View Post
You May Also Like
View Post
  • Articles
  • Profiles

Suheir Rasul: Protecting Human Dignity

  • Gevorg Tamamyan
  • 4 July 2025
View Post
  • Articles
  • Profiles

Curious, Rejected,Accepted: An ESO Fellow’s Road to Becoming an Oncologist

  • Amalya Sargsyan
  • 3 July 2025
View Post
  • Articles

The Dawn of Empathetic Intelligence in Oncology

  • Albertina
  • 2 July 2025
View Post
  • Articles
  • Delivery of Care

Towards a Familial Cancer Service for Chile

  • Myriam Vidal Valero
  • 25 June 2025
View Post
  • Articles
  • Featured

Agents of Mutation: Pathogens as Catalysts of Carcinogenesis

  • Adriana Albini
  • 25 June 2025
View Post
  • Articles
  • Delivery of Care

Traditional Chinese Medicine: Building a Bridge to Modern Oncology

  • Tina Jiang
  • 25 June 2025
View Post
  • Articles
  • Profiles

Alberto Costa: The Father of Seven Children

  • Gevorg Tamamyan
  • 17 June 2025
View Post
  • Delivery of Care
  • Senza categoria

Is It Biology or Geography That Decides Who Survives Childhood Cancer?

  • Shushan Hovsepyan
  • 5 June 2025
search
CancerWorld #105 Download CancerWorld #104 Download CancerWorld #103 Download CancerWorld #102 Download CancerWorld #101 Download or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • How a Brain-Destroying Protein Became Cancer’s Ally: Alpha-Synuclein Emerges as a New Target in Melanoma
    • 4 July 2025
  • CancerWorld #105 (July 2025)
    • 2 July 2025
  • How a Chicken Egg Model Could Transform Pediatric Cancer Treatment in Canada
    • 20 June 2025
  • Microbiota-Derived Bile Acids as Androgen Receptor Antagonists Enhance Anti-Tumour Immunity
    • 19 June 2025
  • Strategies Needed to Prioritise Screening in Survivors of Childhood Cancer
    • 4 June 2025
Article
  • Suheir Rasul: Protecting Human Dignity
    • 4 July 2025
  • Equity:The Word That Shaped Her Career From The Lab To The White House:The Story Of Catharine Young
    • 4 July 2025
  • Curious, Rejected,Accepted: An ESO Fellow’s Road to Becoming an Oncologist
    • 3 July 2025
Social

Would you follow us ?

Contents
  • Suheir Rasul: Protecting Human Dignity
    • 4 July 2025
  • Equity:The Word That Shaped Her Career From The Lab To The White House:The Story Of Catharine Young
    • 4 July 2025
  • Curious, Rejected,Accepted: An ESO Fellow’s Road to Becoming an Oncologist
    • 3 July 2025
MENU
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner
Cancerworld Magazine
  • About us
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is published by OncoDaily (P53 Inc.) | Mailing Address: 867 Boylston st, 5th floor, Ste 1094 Boston, MA 02116, United States | [email protected]

Archivio Cancerworld

Input your search keywords and press Enter.